/ Press Releases
2024.04
Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
2023/03
TWi officially launches its Testosterone Topical Solution CIII (Equivalent to Axiron®) in TWi label
2023/03
TWi’ ANDA for Diltiazem HCL SR Capsules (equivalent to Cardizem SR®) has been officially approved by US FDA
2023/01
TWi officially launches its Guanfacine HCl Tablets in TWi label
2022/12
TWi’ ANDA for Dicyclomine Hydrochloride Capsule (equivalent to BENTYL ®) has been officially approved by US FDA